5min chapter

Breakpoints cover image

#83 – Dosing Consult: Sulfamethoxazole/trimethoprim

Breakpoints

CHAPTER

Trim Sulfa and MRSA Skin and Soft Tissue Infections

The 2014 IDSA SSTI guidelines list trim sulfa as a recommended agent for perulent infections where MRSA is a likely pathogen. Trim-Sulfo certainly has some merit in the treatment of bone and joint infections that are also caused by MRSA. And this is due, in part, to exogenous thymidine that can be found in the body which acts as a salvage pathway for folate synthesis.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode